PubMed Health⌕ Search

PubMed · 9120093

Molecular diagnostics for dairy-borne pathogens.

Abstract

Advances in diagnostic assays based on nucleic acids will revolutionize the ability of the industry to maintain the safety of dairy foods. Two complementary assay formats are explored, one of which permits the rapid detection of bacterial pathogens and the other the identification of reservoirs of these pathogens. The first format is an assay based on the polymerase chain reaction that employs homogeneous detection (TaqMan polymerase chain reaction detection; Perkin Elmer, Applied Biosystems Division, Foster City, CA) of the target sequence. This assay has been applied to the detection of Listeria monocytogenes. A primary problem with current assays that are based on polymerase chain reaction is the complexity of sample handling and the quantification of the initial target number. This fluorogenic assay takes advantage of the endogenous 5',3'-endonuclease activity in Taq DNA polymerase. Approximately 100 samples can be analyzed in 2 to 3 h with a sensitivity of < 50 cells and a dynamic range of > 1000-fold. The TaqMan polymerase chain reaction detection assay is a robust format that is readily applicable to a wide array of other pathogens found in foods and in the environment. The second format is an instrument for automated ribosomal RNA analysis (Riboprinter; DuPont, Wilmington, DE) that can be used to locate the reservoirs harboring the bacterial pathogen. Use of this typing method it has been shown that, although a number of different ribotypes can be isolated from a single environmental sample, only a selected number of these strains apparently have the ability to cause disease. The future of food microbiology lies in the development and integration of molecular methods that can be automated into a testing regimen that extends from the farm to finished products.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C A Batt. 1997. Molecular diagnostics for dairy-borne pathogens.. https://doi.org/10.3168/jds.s0022-0302(97)75931-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Persistent bacterial infections and primary immune disorders.

Mycobacteria, Salmonella and Helicobacter species have all evolved mechanisms to evade host defenses and cause persistent infection in humans. Host control of mycobacteria and Salmonella is largely achieved by the IFN-gamma/IL-12 pathway. Immune disorders affecting this pathway are characterized by disseminated infections with environmental or nontuberculous mycobacteria. Helicobacter is a predominantly extracellular bacterium that uses its remarkable genetic diversity (as well as other mechanisms) in order to evade host defenses. The importance of humoral immunity in containing Helicobacter infections to the mucosal surface is illustrated by the primary immune disorder, X-linked agammaglobulinemia in which patients are prone to chronic bacteremia and skin infections by Helicobacter and related species such as Flexispira and Campylobacter. Exploration of these particular infections in their specific immune defects sheds light on both host and bacterial mechanisms that have implications for pathogenesis and therapy.

Bacterial Infections↗

The importance of vaccination.

We have vaccines for nearly thirty of the more than seventy infectious diseases which are pathogenic for humans. Most of the vaccines, especially those to prevent childhood diseases, are highly effective with a high safety profile. Vaccines are being developed against many of the other bacteria and viruses, and some parasites. Occasionally, a new vaccine has to be withdrawn because of unexpected side effects. Smallpox remains the only infectious disease to have been eradicated. The Global Program to eradicate poliomyelitis initiated in 1988, has unfortunately run into difficulties. A few children immunised with the Sabin oral vaccine fail to clear the virus which can mutate over some years into a pathogenic form and spread rapidly unless large vaccination programs are re-introduced. Of major concern are emerging and re-emerging infectious diseases, especially HIV, for which there is currently no vaccine. Fortunately, new techniques are becoming available making it possible to consider developing vaccines based on inducing strong cell-mediated immune responses to control the agent's replication when antigenic variation in surface antigens (e.g. HIV, influenza) makes classical techniques based on induction of antibody responses less attractive.

Bacterial Infections↗